Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France

Completed

• Conditions: Cardiovascular Risk

• Registration Number: NCT01039402
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to evaluate connection between GP's estimation of cardiovascular risk and theoretical calculation.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12
• Study First Submitted: 2009-12-24
• Study First Submitted QC: 2009-12-24
• Study First Posted: 2009-12-25
• Primary Completion: 2010-01
• Study Completion: 2010-01
• Status Verified: 2010-09
• Last Update Submitted: 2010-09-14
• Last Update Posted: 2010-09-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 13502

Inclusion Criteria

• Adults 50 years old and over, visiting their GPs

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate connection between GP's estimation of cardiovascular risk and theoretical calculation (according to guidelines and validated scales (such as risk score profile in the Framingham Heart study or the SCORE risk estimation))	At the end of the study

Secondary Outcome Measures

Name	Time	Method
To estimate the number of cardiovascular risk patients, that have not been identified	At the end of the study
To characterize those patients according to their theoretical cardiovascular risk (high, medium, low)	At the end of the study
to reveal GP's estimation of cardiovascular risk is especially driven by LDL	At the end of the study

Trial Locations

Locations (1)

Research Site; 🇫🇷 Woerth, France